Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Lantus
Active Ingredient: Insulin glargine 100IU/mL equivalent to 3.6378mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: Aventis Pharma Deutschland GmbH, Frankfurt am Main, Germany
Product: Taxotere
Active Ingredient: Docetaxel trihydrate 40mg/mL
Dosage Form: Solution for concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Aventis Pharma Specialites, Vitry-Sur-Seine, France
Aventis Pharma, Dagenham, Essex, United Kingdom
Dated this 9th day of January 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).